176 results
Page 5 of 9
8-K
EX-3.1
g2k68
12 Oct 07
Amendments to Articles of Incorporation or Bylaws
12:00am
S-3
suyny4me fh3x8rh0w
1 Oct 07
Shelf registration
12:00am
8-K
EX-10.1
12blro
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
1623ily0
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
EX-99.1
xa11f59f0h c4d63y6mt
27 Jul 06
2ND Quarter 2006 Financial Results and Oxyadf™ Tablet Development Status
12:00am
S-8
EX-10.1
5i7p6cu m22
10 Apr 06
Registration of securities for employees
12:00am
8-K
EX-10.3
q4qf8c
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.1
9gy9wm6j
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.4
4kyuqts vcakh
23 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
rwsu27myf4wp
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.4
6duilm4 vqirm0sj
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am